LogicBio Therapeutics, Inc.【LOGC】 業績推移・財務諸表

(単位:千ドル) 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25
売上高 772,000 656,000 368,000 189,000 134,000 125,000 96,000 78,000 60,000 36,000 7,000 - -
売上成長率(%) - - - - -
売上原価 335,000 272,000 201,000 125,000 92,000 91,000 76,000 62,000 46,000 30,000 6,000 - -
売上総利益 437,000 384,000 167,000 64,000 42,000 34,000 20,000 16,000 14,000 6,000 1,000 - -
売上総利益率(%) - -
研究開発費 51,000 52,000 54,000 66,000 46,000 42,000 51,000 38,000 38,000 22,000 4,000 - -
営業費用 563,000 498,000 230,000 126,000 133,000 162,000 113,000 99,000 94,000 59,000 20,000 3,000 6,000
営業利益 -126,000 -114,000 -63,000 -62,000 -91,000 -128,000 -93,000 -83,000 -80,000 -53,000 -19,000 -3,000 -6,000
営業利益率 (%) - -
経常(税引前)利益 -126,000 -106,000 -60,000 -60,000 -89,000 -122,000 -89,000 -77,000 -77,000 -53,000 -13,000 -1,000 -4,000
経常(税引前)利益率(%) -16.32 -16.16 -16.3 -31.75 -66.42 -97.6 -92.71 -98.72 -128.33 -147.22 -185.71 - -
法人税等合計 2,000 5,000 4,000 - 1,000 2,000 - 3,000 3,000 6,000 0 0 0
実効税率(%) - -
純利益 -128,000 -111,000 -64,000 -60,000 -90,000 -124,000 -89,000 -80,000 -80,000 -59,000 -13,000 -1,000 -4,000
純利益率(%) - -
一株あたり利益 - - - - -0.13 -0.18 -3.83 -3.38 -3.35 -2.43 -0.5 -0.04 -0.27
希薄化後一株あたり利益 - - - - -0.13 -0.18 -3.83 -3.38 -3.35 -2.43 -0.5 -0.04 -0.27
EBITDA - - - - - - - - -
EBITDAマージン(%) - - - - - - - - -